Biomarkers for PD-1 checkpoint inhibition

Suzanne L. Topalian of Johns Hopkins University School of Medicine Sidney Kimmel Comprehensive Cancer Center discusses Biomarkers for PD-1 checkpoint inhibition at the Kidney Cancer meeting in Chicago